The effect of opiates upon prostatic carcinoma cell growth

Biochem Biophys Res Commun. 1988 Jun 16;153(2):722-7. doi: 10.1016/s0006-291x(88)81154-9.

Abstract

The effect of opiate receptor agonists upon cell growth of the prostatic carcinoma cell line DU145 were studied. Dynorphin-A increased growth significantly with a peak response at 10(-13) M, of 21 +/- 4% (mean +/- SEM). The dose response curve had a typical inverted-U shape. Dynorphin fragments 1-13 and 1-7 also increased growth at 10(-13) M, while the 2-13 fragment failed to increase growth. Naloxone increased growth at high concentration (10(-7) M) suggesting a stimulatory effect, while at the same time blocking the effect of dynorphin-A. This data demonstrates that agents which stimulate opiate receptors, especially the kappa receptor agonist dynorphin, increase the growth of prostatic carcinoma, and that this effect is controlled by changes at the N-terminal end of the peptide. This effect is blocked by Naloxone.

MeSH terms

  • Cell Division / drug effects*
  • Dose-Response Relationship, Drug
  • Dynorphins / pharmacology
  • Enkephalin, Leucine / pharmacology
  • Male
  • Morphine / pharmacology
  • Naloxone / pharmacology
  • Narcotics / pharmacology*
  • Prostatic Neoplasms / pathology*
  • Receptors, Opioid / drug effects*
  • Tumor Cells, Cultured
  • beta-Endorphin / pharmacology

Substances

  • Narcotics
  • Receptors, Opioid
  • Naloxone
  • Enkephalin, Leucine
  • beta-Endorphin
  • Dynorphins
  • Morphine